Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254730674> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4254730674 endingPage "2044" @default.
- W4254730674 startingPage "2037" @default.
- W4254730674 abstract "The platelet glycoprotein IIb/IIIa inhibitors, although effective in reducing ischaemic complications of percutaneous coronary intervention, are used in few coronary stent implantation procedures. ESPRIT (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy) is a randomised, placebo-controlled trial to assess whether a novel, double-bolus dose of eptifibatide could improve outcomes of patients undergoing coronary stenting.We recruited 2064 patients undergoing stent implantation in a native coronary artery. Immediately before percutaneous coronary intervention, patients were randomly allocated to receive eptifibatide, given as two 180 microg/kg boluses 10 min apart and a continuous infusion of 2.0 microg/kg/min for 18-24 h, or placebo, in addition to aspirin, heparin, and a thienopyridine. The primary endpoint was the composite of death, myocardial infarction, urgent target vessel revascularisation, and thrombotic bailout glycoprotein IIb/IIIa inhibitor therapy within 48 h after randomisation. The key secondary endpoint was the composite of death, myocardial infarction, or urgent target vessel revascularisation at 30 days.The trial was terminated early for efficacy. The primary endpoint was reduced from 10.5% (108 of 1024 patients on placebo [95% CI 8.7-12.4%]) to 6.6% (69 of 1040 [5.1-8.1%]) with treatment (p=0.0015). The key 30 day secondary endpoint was also reduced, from 10.5% (107 of 1024 patients on placebo [8.6-12.3%]) to 6.8% (71 of 1040 [5.3-8.4%]; p=0.0034). There was consistency in reduction of events across all components of the composite endpoint and among the major subgroups. Major bleeding was infrequent but arose more often with eptifibatide than placebo (1.3%, 13 of 1040 [0.7-2.1%]) vs 0.4%, 4 of 1024 [0.1-1.0%]; p=0.027).Routine glycoprotein IIb/IIIa inhibitor pretreatment with eptifibatide substantially reduces ischaemic complications in coronary stent intervention and is better than a strategy of reserving treatment to the bailout situation." @default.
- W4254730674 created "2022-05-12" @default.
- W4254730674 date "2000-12-01" @default.
- W4254730674 modified "2023-10-16" @default.
- W4254730674 title "Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial" @default.
- W4254730674 cites W1571377358 @default.
- W4254730674 cites W1596397105 @default.
- W4254730674 cites W1963594660 @default.
- W4254730674 cites W1993578099 @default.
- W4254730674 cites W1994478916 @default.
- W4254730674 cites W2007516629 @default.
- W4254730674 cites W2010111546 @default.
- W4254730674 cites W2021306263 @default.
- W4254730674 cites W2023820419 @default.
- W4254730674 cites W2031057628 @default.
- W4254730674 cites W2037465103 @default.
- W4254730674 cites W2052899600 @default.
- W4254730674 cites W2078113728 @default.
- W4254730674 cites W2085869089 @default.
- W4254730674 cites W2099058771 @default.
- W4254730674 cites W2099111111 @default.
- W4254730674 cites W2121964226 @default.
- W4254730674 cites W2141117188 @default.
- W4254730674 cites W2230838014 @default.
- W4254730674 cites W2281862598 @default.
- W4254730674 cites W2313726388 @default.
- W4254730674 cites W2339691016 @default.
- W4254730674 cites W2395313915 @default.
- W4254730674 cites W3022148767 @default.
- W4254730674 doi "https://doi.org/10.1016/s0140-6736(00)03400-0" @default.
- W4254730674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11145489" @default.
- W4254730674 hasPublicationYear "2000" @default.
- W4254730674 type Work @default.
- W4254730674 citedByCount "502" @default.
- W4254730674 countsByYear W42547306742012 @default.
- W4254730674 countsByYear W42547306742013 @default.
- W4254730674 countsByYear W42547306742014 @default.
- W4254730674 countsByYear W42547306742015 @default.
- W4254730674 countsByYear W42547306742016 @default.
- W4254730674 countsByYear W42547306742017 @default.
- W4254730674 countsByYear W42547306742018 @default.
- W4254730674 countsByYear W42547306742019 @default.
- W4254730674 countsByYear W42547306742020 @default.
- W4254730674 countsByYear W42547306742021 @default.
- W4254730674 countsByYear W42547306742022 @default.
- W4254730674 countsByYear W42547306742023 @default.
- W4254730674 crossrefType "journal-article" @default.
- W4254730674 hasConcept C126322002 @default.
- W4254730674 hasConcept C141071460 @default.
- W4254730674 hasConcept C142724271 @default.
- W4254730674 hasConcept C164705383 @default.
- W4254730674 hasConcept C168563851 @default.
- W4254730674 hasConcept C203092338 @default.
- W4254730674 hasConcept C204787440 @default.
- W4254730674 hasConcept C27081682 @default.
- W4254730674 hasConcept C2777628954 @default.
- W4254730674 hasConcept C2780400711 @default.
- W4254730674 hasConcept C2781056559 @default.
- W4254730674 hasConcept C42219234 @default.
- W4254730674 hasConcept C500558357 @default.
- W4254730674 hasConcept C71924100 @default.
- W4254730674 hasConceptScore W4254730674C126322002 @default.
- W4254730674 hasConceptScore W4254730674C141071460 @default.
- W4254730674 hasConceptScore W4254730674C142724271 @default.
- W4254730674 hasConceptScore W4254730674C164705383 @default.
- W4254730674 hasConceptScore W4254730674C168563851 @default.
- W4254730674 hasConceptScore W4254730674C203092338 @default.
- W4254730674 hasConceptScore W4254730674C204787440 @default.
- W4254730674 hasConceptScore W4254730674C27081682 @default.
- W4254730674 hasConceptScore W4254730674C2777628954 @default.
- W4254730674 hasConceptScore W4254730674C2780400711 @default.
- W4254730674 hasConceptScore W4254730674C2781056559 @default.
- W4254730674 hasConceptScore W4254730674C42219234 @default.
- W4254730674 hasConceptScore W4254730674C500558357 @default.
- W4254730674 hasConceptScore W4254730674C71924100 @default.
- W4254730674 hasIssue "9247" @default.
- W4254730674 hasLocation W42547306741 @default.
- W4254730674 hasLocation W42547306742 @default.
- W4254730674 hasOpenAccess W4254730674 @default.
- W4254730674 hasPrimaryLocation W42547306741 @default.
- W4254730674 hasRelatedWork W2101065585 @default.
- W4254730674 hasRelatedWork W2219165420 @default.
- W4254730674 hasRelatedWork W2355614377 @default.
- W4254730674 hasRelatedWork W2375584960 @default.
- W4254730674 hasRelatedWork W2782203991 @default.
- W4254730674 hasRelatedWork W2918435398 @default.
- W4254730674 hasRelatedWork W2970909790 @default.
- W4254730674 hasRelatedWork W3029448752 @default.
- W4254730674 hasRelatedWork W45326695 @default.
- W4254730674 hasRelatedWork W98764081 @default.
- W4254730674 hasVolume "356" @default.
- W4254730674 isParatext "false" @default.
- W4254730674 isRetracted "false" @default.
- W4254730674 workType "article" @default.